Human Immunodeficiency Virus Type 1 (HIV-1) Antikörper (HRP)
Kurzübersicht für Human Immunodeficiency Virus Type 1 (HIV-1) Antikörper (HRP) (ABIN112750)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Molar Ratio: HRP:IgG substitution is 2-3
-
Immunogen
- Human isolate confirmed
-
-
-
-
Applikationshinweise
-
Enzyme immunoassay application.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1-2 mg/mL (OD280 nm, E0.1% = 1.4)
-
Buffer
- PBS containing 10 mg/mL BSA as stabilizer and 0.002 % Thimerosal as preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Human Immunodeficiency Virus Type 1 (HIV-1)
-
Andere Bezeichnung
- HIV-1
-
Substanzklasse
- Virus
-
Hintergrund
- HIV is a highly variable virus which mutates very readily. This means there are many different strains of HIV, even within the body of a single infected person. The strains of HIV1 can be classified into three groups : the "major" group M, the "outlier" group O and the "new" group N. These three groups may represent three separate introductions of simian immunodeficiency virus into humans. Group O appears to be restricted to West-Central Africa and group N, discovered in 1998 in Cameroon, is extremely rare. More than 90 % of HIV1 infections belong to HIV1 group M.Synonyms: HIV-I, HIV1, Human immunodeficiency virus type 1
Target
-